Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2008
10/09/2008US20080248509 Method for diagnosis of alzheimer's disease with determination of lasp-1 immunoreactivity
10/09/2008US20080248143 Pulsatilla Spp. Extracts Effective in Brain Function
10/09/2008US20080248137 Magnesium-Containing Food Compositions
10/09/2008US20080248123 zolpidem, phenytoin; controlled release; surface modifier selected from anionic surfactants, cationic surfactants, zwitterionic surfactants, nonionic surfactants, surface active biological modifiers; hydroxypropyl methyl cellulose, hydrogenated oil or polyvinylpyrrolidone as rate controlling polymer
10/09/2008US20080248118 Antioxidant superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase, glutathione-S-transferase hemeoxygenase, acetyl salicyclic acid, mannitol, captopril, Arg, or pyruvate; vitamins(lycopene, lutein, xeaxanthine, Vitamin A, carotene); administered via carotid artery or juguar vein
10/09/2008US20080248113 An opioid selected from oxymorphone, hydromorphone, morphine, oxycodone hydrochloride with potential for abuse and a synthetic or natural polymer (polyoxyethylene glycol, polyethylene, polypropylene, PVC, polycarbonate, polystyrene, polyacrylates; delayed release; nonadduactive
10/09/2008US20080248110 Pharmaceutical Compositions Useful in the Treatment of Pain
10/09/2008US20080248106 Melatonin-based composition for improved sleep
10/09/2008US20080248103 Melatonin-based composition for improved sleep
10/09/2008US20080248100 Magnesium compositions and uses thereof
10/09/2008US20080248099 using insulin for making medicine to treat Alzheimer's disease, brain atrophy associated with diabetes, Parkinson's disease, Huntington's Disease, senile dementia, multiple sclerosis, dementia associated with Acquired Immunodeficiency Syndrome (AIDS), Pick's Disease, stroke, trauma; tolbutamide
10/09/2008US20080248084 Method of treating acute dysfunction of cardiac muscle
10/09/2008US20080248082 Deliver platelet rich plasma, sodium bicarbonate, calcium gluconate, choline chloride buffers, thrombin, collagen, epinephrine releasate, via catheter; coat suture, stent, screw, plate implants with plasma
10/09/2008US20080248081 Method of treating chronic dysfunction of cardiac muscle
10/09/2008US20080248070 pharmaceutical composition including therapeutically effective amounts of at least one HMG-CoA reductase inhibitor present as a dyhydroxyacid salt and at least one additional therapeutic agent
10/09/2008US20080248041 Using membrane protein as evauluative tool in identifying modulators for prevention and treatment of neuropathic pain and nervous system disorders
10/09/2008US20080248035 Pyrrole derivatives, dyslipidemic agents (cholesteryl ester transfer protein inhibitors), antiobesity agents (serontonin receptor inhibitors), antihyperglycemic agents (insulin sensitizing agents/PPAR agonists), anti-inflammatory agents
10/09/2008US20080248029 Prevention and treatment of amyloidogenic diseases
10/09/2008US20080248023 Treating and preventing amyloid A amyloidosis via enhancing immune response to amyloid A light-chain protein or serum amyloid A precursor protein
10/09/2008US20080248022 Using inflammatory marker concentration as diagnostic/therapeutic indicator for administering vaccine agent for treatment and/or prevention of neurodegenerative disorders
10/09/2008US20080248004 Bone marrow and/or cord stem cell culture for use in treatment of nervous system disorders; tissue engineering and repair; regenerative medicine
10/09/2008US20080247954 Especially oxazole, thiazole and imidazole compounds 2-substituted with phenyl -cycloalkyl or -bicycloalkyl groups; drug screening
10/09/2008CA2682727A1 Indoledione derivative
10/09/2008CA2682715A1 New imidazo[4,5-b]pyridine-7-carboxamides 704
10/09/2008CA2682550A1 Peripheral opioid receptor antagonists and uses thereof
10/09/2008CA2682473A1 Novel pyrrolinone derivative and pharmaceutical composition comprising the same
10/09/2008CA2682377A1 Heteroaryl derivatives
10/09/2008CA2682375A1 Medicinal composition, food or drink having effect of enhancing parasympathetic nervous activity
10/09/2008CA2682374A1 Medicinal composition, food or drink having effect of enhancing sympathetic nervous activity
10/09/2008CA2681979A1 Indole derivatives having cpla2 inhibiting activity and applications and production methods of the same
10/09/2008CA2681733A1 Pyridine and pyrimidine derivatives as mglur2 antagonists
10/09/2008CA2679728A1 Sub-type selective azabicycloalkane derivatives
10/08/2008EP1978362A2 Cross beta structure comprising amyloid binding proteins and methods for detection of the cross beta structure, for modulating cross beta structures fibril formation and for modulating cross beta structure-mediated toxicity
10/08/2008EP1978025A1 Novel kappa receptor selective opioid peptides
10/08/2008EP1977746A1 Methods and compositions for reduction of side effects of therapeutic treatments
10/08/2008EP1977744A1 Polymorphic Form alpha of (S)-Pregabalin and process for its preparation
10/08/2008EP1977741A2 Use of renin inhibitors in therapy
10/08/2008EP1977736A1 Oral pulsed dose drug delivery system
10/08/2008EP1977735A1 Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders
10/08/2008EP1977249A2 Method of diagnosis and method of treatment
10/08/2008EP1976877A2 Monoclonal antibodies against amyloid beta protein and uses thereof
10/08/2008EP1976851A2 Phenoxy-substituted pyrimidines as adenosine receptor antagonists
10/08/2008EP1976842A1 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
10/08/2008EP1976841A1 Heterocyclic amide derivatives as calcium channel blockers
10/08/2008EP1976839A2 Compounds and methods for modulating protein trafficking
10/08/2008EP1976833A2 Heterocycle substituted amide and sulfur amide derivatives as histone deacetylase (hdac) inhibitors
10/08/2008EP1976823A1 Dibenzene derivatives as calcium channel blockers
10/08/2008EP1976562A1 Water-soluble films comprising low-viscosity alginates
10/08/2008EP1976525A2 Piperidine and piperazine derivatives
10/08/2008EP1976524A1 Use of a combination of morphine and at least one opiate antagonist for treatment of opiate dependency and for prevention of non-oral opiate abuse in opiate addicts
10/08/2008EP1976518A1 Methods and compositions for treating schizophrenia
10/08/2008EP1976514A2 Neuronal nicotinic receptor ligands and their use
10/08/2008EP1976507A2 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of epilepsy
10/08/2008EP1976506A1 Cannabinoid-containing plant extracts as neuroprotective agents
10/08/2008EP1976503A2 Gastric retentive gabapentin dosage forms and methods for using same
10/08/2008EP1976502A1 Small molecule inhibitors of pdz interactions
10/08/2008EP1976496A1 Overall therapeutic approach in the treatment of neurodegenerative diseases
10/08/2008EP1976396A2 Composition comprising polyunsaturated fatty acids for improving membrane composition
10/08/2008EP1976395A2 Composition comprising polyunsaturated fatty acids for improving membrane composition
10/08/2008EP1976381A2 Tri-substituted 2-benzhydryl-5-benzlamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel 3,6-disubstituted pyran derivatives
10/08/2008EP1781596B1 Amino acid derived prodrugs of propofol compositions and uses thereof
10/08/2008EP1778208A4 Extended-release capsules comprising venlafaxine hydrochloride
10/08/2008EP1734940B1 Combinations of deramciclane and opioids for use as analgesics
10/08/2008EP1646390B1 A1 adenosine receptor antagonists
10/08/2008EP1539693B9 Cannabinoid receptor agonists
10/08/2008EP1523469B1 Cinnamide derivatives
10/08/2008EP1499360B1 Formulation comprising buprenorphine
10/08/2008EP1487469B1 Co-beadlet of dha and rosemary
10/08/2008EP1485390B1 Bicyclic pyridine and pyrimidine p38 kinase inhibitors
10/08/2008EP1485363B1 Cyclic amides
10/08/2008EP1419144B1 Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues
10/08/2008EP1390059B1 Improved neuronal gene transfer
10/08/2008EP1389100B1 Novel methods for the treatment and prevention of pain using stress-activated protein kinase inhibitors
10/08/2008EP1379246B1 Nociceptin analogs
10/08/2008EP1335902B1 Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them
10/08/2008EP1333818B1 Titratable dosage transdermal delivery system
10/08/2008EP1274398B1 Methods for thepreparation of effervescent granules
10/08/2008EP1253918B1 Compositions comprising modafinil for the treatment of attention deficit hyperactivity disorder
10/08/2008EP1064298B1 Inhibitors of caspases
10/08/2008EP1032667B1 Platelet specific antigens and their pharmacological uses
10/08/2008CN101282974A Benzimidazole derivatives as SIRTUIN modulators
10/08/2008CN101282964A Oxopyridyl quinoline amides as NK3 receptor modulators
10/08/2008CN101282961A Alkylpyridyl quinolines as NK3 receptor modulators
10/08/2008CN101282957A 新的药物化合物 New pharmaceutical compounds
10/08/2008CN101282954A Therapeutic agents
10/08/2008CN101282953A Therapeutic agents
10/08/2008CN101282952A Cyclic n-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
10/08/2008CN101282951A N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
10/08/2008CN101282946A 新的半胱氨酸蛋白酶抑制剂及它们的治疗应用 The new cysteine ​​protease inhibitors and their therapeutic applications
10/08/2008CN101282938A Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
10/08/2008CN101282923A 2,5-bis-diamimne [1 , 4] benzoquinone-derivatives
10/08/2008CN101282761A Benzimidazole derivatives as SIRTUIN modulators
10/08/2008CN101282740A Treatment of optic neuritis
10/08/2008CN101282726A Use of 3,11b-cis-dihydrotetrabenazine for the treatment of symptons of huntington' s disease
10/08/2008CN101282721A Composition for relieving subjective symptoms of fatigue
10/08/2008CN101280016A Cocaine-and amphetamine-regulated transcript peptides single-chain antibody and application thereof
10/08/2008CN101280013A Anti-amyloid antibodies, compositions, methods and uses
10/08/2008CN101279945A Extracting method of valerine
10/08/2008CN101279085A Chinese medicinal composition for treating hypersomnia and method of preparing the same
10/08/2008CN101279079A Chinese medicine composite for nourishing kidney, removing dampness and strengthening muscle, and relaxing tendons and collaterals
1 ... 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 ... 1833